Filing Details
- Accession Number:
- 0001477449-24-000043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 16:09:12
- Reporting Period:
- 2024-03-01
- Accepted Time:
- 2024-03-05 16:09:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2001935 | P. Nikolaos Nanis | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-01 | 1,479 | $0.00 | 66,510 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 505 | $0.00 | 67,015 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 894 | $0.00 | 67,909 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 4,340 | $0.00 | 72,249 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 467 | $0.00 | 72,716 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-04 | 2,866 | $14.52 | 69,850 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Performance Stock Units | Acquisiton | 2024-03-01 | 4,437 | $0.00 | 4,437 | $0.00 |
Common Stock | Performance Stock Units | Disposition | 2024-03-01 | 1,479 | $0.00 | 1,479 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 505 | $0.00 | 505 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 894 | $0.00 | 894 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 4,340 | $0.00 | 4,340 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 467 | $0.00 | 467 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,437 | No | 4 | A | Direct | ||
2,958 | No | 4 | M | Direct | ||
2,023 | No | 4 | M | Direct | ||
4,472 | No | 4 | M | Direct | ||
8,681 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct |
Footnotes
- Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
- The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 2, 2021, the reporting person was granted 1,400 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.